Institutional investors purchased a net $630.5 thousand shares of VICL during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 39.93% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ARIEL INVESTMENTS LLC Bought 2.0 Million shares of Vical Inc
TFS CAPITAL LLC Bought 1.3 Million shares of Vical Inc
FIDELITY MANAGEMENT & RESEARCH C... Bought 864.6 Thousand shares of Vical Inc